Merck

Showing 15 posts of 363 posts found.

Mumbai

Merck teams up with Sun on emerging markets generics

April 12, 2011
Sales and Marketing India, Merck, Sun Pharma, emerging markets

Merck Inc has created a joint venture with Indian firm Sun Pharmaceutical Industries to develop, manufacture and market branded generics …

Merck acquires eyecare specialist Inspire

April 6, 2011
Research and Development, Sales and Marketing Inspire, Merck, eye care

Merck & Co is to buy ophthalmic specialist Inspire Pharmaceuticals in a $430 million deal which sees it move further …

Merck drops oral anticoagulant

March 25, 2011
Merck, Pradaxa, Xarelto, anticoagulant, atrial fibrilation, vorapaxar

Merck has given the rights to its oral anticoagulant betrixaban back to Portola Pharmaceuticals after a review of its late …

Bayer-helmed oncology biomarker project launched

March 14, 2011
Manufacturing and Production, Research and Development AstraZeneca, Bayer, Janssen, Max Planck Institute, Merck, OncoTrack, Pfizer, Roche, biomarkers, oncology

A project to develop the next generation of oncology biomarkers has been launched in Berlin. The pharma industry and European …

Fujifilm buys into bio with Merck acquisitions

March 2, 2011
Manufacturing and Production Biomanufacturing, Fujifilm, Merck, Merck & Co, Merck/MSD Biomanufacturing Network, contract manufacturing

Japanese photography and imaging company Fujifilm continued its diversification into other sectors with the acquisition of the Merck/MSD Biomanufacturing Network, …

Merck repels jaw injury claim

February 15, 2011
Sales and Marketing Fosamax, Merck, US, lawsuit

A New Jersey state court jury has found in favour of Merck & Co in the company’s ongoing legal battle …

US Senate takes aim at prescription drug shortages

February 15, 2011
Manufacturing and Production Merck, Zostavax, shortages, supply chain

A bill aimed at tackling the ongoing problem of prescription drug shortages in the US has been introduced in the …

Pfizer's Les Meningo – Smash Pursuit iPhone app

Digital Pharma: Pfizer, J&J and Merck withdraw iPhone apps

January 7, 2011
Medical Communications Android, Blackberry, Digital Pharma blog, Johnson & Johnson, Merck, Pfizer, apps, ipad, iphone

Big pharma companies have pulled a number of apps from the iTunes store, but it’s not a sign the industry …

Merck acquires innovative insulin firm SmartCells

December 3, 2010
Research and Development Merck, Merck & Co, SmartCells, diabetes, insulin

Merck has bolstered its early stage diabetes portfolio with the acquisition of SmartCells, a private pharma firm that’s developing a …

New chief executive for Merck & Co

December 1, 2010
Manufacturing and Production, Research and Development, Sales and Marketing Kenneth Frazier, Merck, Merck & Co, Richard Clark, Schering-Plough

Kenneth Frazier is to be the next chief executive of Merck & Co from 1 January 2011 following his election …

Vytorin cuts heart problems in kidney patients

November 23, 2010
Sales and Marketing Merck, Vytorin, cardiovascular, simvastatin

Vytorin has been shown to reduce potentially heart problems in patients with chronic kidney disease (CKD) in a new study. …

Caelyx rights to revert back to Janssen

September 30, 2010
Sales and Marketing Caelyx, Janssen, Merck

Marketing rights for cancer treatment Caeylx outside the US will be returned to Janssen from Merck after a licensing deal …

J&J and Merck heading for showdown over drug rights

September 8, 2010
Sales and Marketing Johnson & Johnson, Merck, Remicade

Johnson & Johnson’s disagreement with Merck over rights to two arthritis drugs is set to come to a head in …

Merck names manufacturing and R&D sites slated for closure

July 12, 2010
Manufacturing and Production, Research and Development Merck, job cuts, manufacturing, research and development

Merck & Co has taken an axe to its network of manufacturing and R&D sites around the world, closing down …

Pfizer and Merck post modest results

May 6, 2010
Sales and Marketing 2010 financials, Merck, Pfizer

The acquisition of Wyeth has added over $5 billion to Pfizer’s revenue buts its own sales fail to shine.  Both …

The Gateway to Local Adoption Series

Latest content